drugset / Trial / NCT05773053
A Study of NT 201 Doses in the Treatment of Platysma Prominence
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to assess the safety and efficacy of NT 201 in adults with moderate to severe platysma prominence.
Timeline
- Start
- 2023-03-22
- Primary completion
- 2023-10-19
- Completion
- 2024-01-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | — | — |
Indications
No indication recorded.